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Matrix Metalloproteinase-19 Expression in
Keratinocytes Is Repressed by Transcription Factors
Tst-1 and Skn-1a: Implications for Keratinocyte
Differentiation
Inken M. Beck1,5, Matthias Mu¨ller1,5, Rolf Mentlein2, Thorsten Sadowski1,6, Markus S. Mueller3, Ralf Paus4
and Radislav Sedlacek1
Matrix metalloproteinase-19 (MMP-19), unlike other members of the MMP family, is expressed in basal
keratinocytes of intact epidermis whereas keratinocytes in suprabasal and higher epidermal layers express this
enzyme only during cutaneous disorders. As the activity of MMP-19 effects proliferation, migration, and
adhesion of keratinocytes we examined whether transcription factors involved in keratinocyte differentiation
repress the expression of MMP-19. Using luciferase reporter assays, POU transcription factors Tst-1 (Oct-6) and
Skn-1a (Oct-11) markedly downregulated the activity of MMP-19 promoter in COS-7 cells and HaCaT
keratinocytes. Tst-1 alone was able to inhibit 85% of the promoter activity. Skn-1a exhibited a weak inhibitory
effect although it synergistically increased effects of Tst-1. HaCaT cells stably transfected with Tst-1 showed a
strong decrease of activity of MMP-19 promoter that correlated with suppression of MMP-19, cytokeratin 14 and
5, decreased cell proliferation, and altered expression of involucrin and loricrin. The expression of MMP-9 was
also significantly reduced in Tst-1 expressing keratinocytes. MMP-2 was substantially affected during its
activation whereas the expression of MMP-28 was unchanged. Our results suggest that Tst-1 and Skn-1a regulate
expression of MMPs in keratinocytes and effect both the expression and activation of these proteolytic
enzymes.
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INTRODUCTION
The mammalian epidermis is a stratified and renewable
protective barrier characterized by keratinocyte differentia-
tion. Keratinocytes adjacent to the basement membrane
represent cells with high proliferative potential that undergo
differentiation as they enter the suprabasal compartment.
These keratinocytes characterized by expression of cytoker-
atin 5 and 14 (K5 and K14) assemble in a single-cell layer
called stratum germinativum (Fuchs and Green, 1980; Fuchs,
1995). During epidermal differentiation in the stratum
spinosum, K5 and K14 are replaced by K1 and K10 (Zhu
et al., 1999). In upper layers, keratinocytes express proteins
typical for the differentiation state such as small prolin-rich
protein-2a, loricrin, involucrin, and profilaggrin (Gibbs et al.,
1990; Mehrel et al., 1990; Hohl et al., 1993; Fischer et al.,
1996; Jang et al., 1996; Eckert et al., 2004). In addition to
characteristic changes in the expression of structural proteins,
various regulatory proteins, adhesion molecules, and pro-
teases undergo tight regulation in order to maintain functions
of the epidermal barrier (Turksen, 2004). This regulation is
controlled by ubiquitous and specific factors. Among the
ubiquitous transcription factors, AP1, AP2, and Sp1 were
reported to be involved in gene regulation during differentia-
tion of keratinocytes (Fuchs, 1995; Eckert et al., 1997a, b). In
addition, transcription factors expressed predominantly in the
epidermis include Tst-1 (Testes-1, Oct-6) and Skn-1a (Skin-
1a/Epoc-1/Oct-11) that belong to the POU family of
transcription factors. Skn-1a is able to enhance epidermal
stratification and transactivate promoters for K10 and small
prolin-rich protein-2a (Andersen et al., 1993; Fischer et al.,
1996; Hildesheim et al., 1999, 2001). Both Skn-1a and Tst-1
repress K14 that is downregulated upon commitment to
terminal differentiation (Faus et al., 1994; Sugihara et al.,
2001).
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Matrix metalloproteinases (MMPs) that are responsible for
the degradation of various components of the extracellular
matrix are upregulated in the skin under pathologic condi-
tions such as cutaneous tumors, infections, or chronic
wounds. MMPs that are indispensable for the completion of
the wound healing process (Madlener et al., 1998; Pilcher
et al., 1998; Pilcher et al., 1999) are generally downregulated
in the intact epidermis. In contrast, MMP-19 shows a different
expression pattern in the epidermis. It is typically expressed
in the basal layer of healthy interfollicular epidermis but
upregulated in suprabasal and spinous layers in psoriasis,
eczema, and tinea (Sadowski et al., 2003b; Suomela et al.,
2003). MMP-19 is also dysregulated in chronic wounds and
cutaneous tumors (Impola et al., 2003, 2005; Sadowski et al.,
2005). The proteolytic activity of MMP-19 is responsible for
increased proliferation of keratinocytes by activating the IGF/
IGF-1R signaling pathway and for promoting the migratory
behavior (Sadowski et al., 2003a). Further promigratory
stimuli originate from processing of extracellular matrix
proteins such as laminin 5 g2, type IV collagen, and fibrin
(Sadowski et al., 2003a, 2005).
Although we reported that increased calcium concentra-
tions and E-cadherin mediate repression of MMP-19 in
keratinocytes (Sadowski et al., 2003a), its regulation in the
epidermis remains largely unknown. Uncovering the me-
chanism leading to accurate repression of MMP-19 could
help to define its pathophysiologic role in the epidermis,
especially its contribution to keratinocyte proliferation and
migration.
In this study we report on the regulation of MMP-19 and
other epidermally expressed MMPs by transcription factors
Tst-1 and Skn-1a that are involved in keratinocyte differentia-
tion. We have shown that Tst-1 and Skn-1a downregulate the
activity of MMP-19 promoter and thus suppress the expres-
sion of this MMP. The expression of MMP-28 remained
unchanged in keratinocytes expressing Tst-1 whereas that of
MMP-9 was markedly reduced. MMP-2 showed slightly
reduced expression whereby its activation was decreased
substantially. Thus, the POU family members Tst-1 and Skn-
1a are transcription factors that exert differential regulation of
MMPs in keratinocytes.
RESULTS
Transcription factors Tst-1 and Skn-1a downregulate MMP-19
Our previous studies showed that MMP-19 is constitutively
expressed in the stratum basale of interfollicular epidermis
and that this expression pattern correlates with that of K14
(Sadowski et al., 2003a, b). Because of the unique expression
pattern of MMP-19 and the proteolytic activity, which effects
migration and adhesion of keratinocytes and promotes cell
proliferation, we asked which factors regulate the expression
of MMP-19 in the epidermis. As K14 is downregulated by
transcription factors Tst-1 (Oct-6) and Skn-1a (Oct-11) we
studied their impact on the expression of MMP-19. Tst-1 and
Skn-1a are specifically involved in the regulation of
keratinocyte differentiation (Faus et al., 1994; Andersen
et al., 1997; Hildesheim et al., 1999; Sugihara et al., 2001).
COS-7 cells were transiently transfected with expression
vectors containing either Tst-1 or Skn-1a. Regulatory effects
were measured using the dual-luciferase assay and a vector
construct containing the 1898-bp stretch of the 50-flanking
promoter region of mmp-19 gene (Mueller et al., 2000).
Although both Tst-1 and Skn-1a exhibited the same
tendency to inhibit the activity of MMP-19 promoter only
Tst-1 showed significant inhibition. The Tst-1-dependent
inhibition of the promoter activity reached 90% (Figure 1a).
No clear relationship between gene dosage and the promoter
activity could be observed (Figure 1a). As Tst-1 and Skn-1a
are expressed in the suprabasal layers alongside, we
investigated their concurrent influence on the MMP-19
promoter. As shown in Figure 1a these two factors may
exhibit a synergistic inhibitory effect on the MMP-19
promoter at low concentrations. The simultaneous transfec-
tion of 0.005mg of each expression vector bearing Tst-1 or
Skn-1a (i.e., 5% of transfected plasmid DNA) reached 65%
inhibition of the promoter activity (Figure 1a). When
transfected alone, Skn-1a did not show significant inhibition
in COS-7 cells and Tst-1 reached a comparable inhibitory
effect at concentrations that are five to 10 times higher (Figure
1a).
In order to prove that Tst-1 and Skn-1a affect the promoter
activity of MMP-19 in keratinocytes we transiently trans-
fected HaCaT cells with the transcription factors (Figure 1b).
Similarly to the effects observed in COS-7 cells, Tst-1 showed
higher inhibition (90%) in comparison to Skn-1a (60%) and
no dose-dependent inhibition was observed. Thus, both POU
factors are able to inhibit the promoter activity of MMP-19 in
keratinocytes whereby Tst-1 appears to have higher inhibitory
capacity.
Because of the profound effects of Skn-1a and Tst-1 on the
activity of MMP-19 promoter, we examined whether the
1,932 bp long 50-flanking region of mmp-19 gene possesses
binding sites for these transcription factors (Mueller et al.,
2000). Although we could not find a consensus sequence for
Skn-1a, the promoter analysis revealed a possible binding site
for Tst-1 starting at position 278 (Figure 1c). This may lead
to the presumption that Tst-1 can theoretically use both the
direct and indirect way of promoter regulation whereas Skn-
1a regulates the promoter activity of MMP-19 indirectly via
protein–protein interaction. Skn-1a represses K14 promoter
via interaction with cAMP response element binding protein
(CREB)-binding protein (Sugihara et al., 2001) and the
analysis of the MMP-19 promoter also disclosed consensus
binding sequences for CREB and CREB protein binding
protein at positions 1917, 1898, and 1398 (Figure 1c).
Inhibition of MMP-19 expression correlates with decreased
proliferation in keratinocytes overexpressing Tst-1
To gather further information on processes that are parallel to
the inhibition of MMP-19 we generated stably transfected
HaCaT cells expressing Tst-1, especially as the promoter of
MMP-19 contains a consensus binding site for this factor and
Tst-1 exhibited more pronounced effects than Skn-1a. Two
clones Tst-1/12 and Tst-1/14 that showed different expression
levels of Tst-1 were selected for further analysis (Figure 2a).
Both clones exhibited tendency to reduce the activity of
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MMP-19 promoter, however, only clone Tst-1/14 that
showed strong overexpression of Tst-1 could markedly and
significantly inhibit the promoter activity (Figure 2b). In
addition, both clones expressing Tst-1 showed decreased cell
proliferation (Figure 2c). The reduced promoter activity and
cell proliferation interrelated with other known effects of Tst-
1. Both clones exhibited increased expression of loricrin
(Figure 2f) whereas involucrin was downregulated (Figure 2d
and e). The downregulation of involucrin is in respect of
epidermal differentiation rather unforeseen as involucrin is
accepted as a marker of keratinocyte differentiation. How-
ever, investigations by Eckert and his co-workers (Welter
et al., 1996; Eckert et al., 2004) showed that the activity of
involucrin promoter in vitro is suppressed by POU factors
such as Tst-1 (SCIP) and Skn-1a. Moreover, both Tst-1-
expressing clones downregulated the expression of K14
(Figure 2g). The expression of K5 was also reduced although
Tst-1/12 showed higher impact on K5 production (Figure 2h).
Thus, cells that ectopically express Tst-1 suppressed MMP-19
promoter and behaved as keratinocytes undergoing epider-
mal differentiation.
Impact of Tst-1 on MMP expression in keratinocytes
As the ectopic expression of Tst-1 in HaCaT keratinocytes
inhibited the promoter activity of MMP-19, we asked if this
transcription factor affects also the protein amount of MMP-19
and other MMPs expressed by keratinocytes, especially
gelatinase A and B, and MMP-28 (Lohi et al., 2001). MMP-
19 could not be detected by immunoblotting of cell lysates
prepared from stably transfected Tst-1 clones (Figure 3), thus,
the protein level correlated with the decreased promoter
activity (Figure 2b). However, the inhibited expression and
reduced promoter activity did not correlate with messenger
RNA levels of MMP-19 that showed tendency to decrease but
no significance at Po0.05 (Figure 3b). Expression of MMP-28
in the Tst-1 clones, analyzed by immunoblotting, did not differ
from untransfected HaCaT cells (Figure 3c). The expression of
MMP-9 was substantially reduced (60%) as could be seen in
gelatin zymography carried out with conditioned media of
cells cultured with fetal calf serum (FCS) (Figure 3d and e).
Although the expression level of MMP-2 decreased only about
20% as elucidated from densitometric analysis of pro-MMP-2,
the activation of MMP-2 was changed considerably. The
Tst-1 clones showed 50% reduction of the gelatinolytic activity
of the 62-kD form of MMP-2 (Figure 3d and e). Similar
inhibitory effects were found in cells cultured without FCS (not
shown). As the activation of pro-MMP-2 was more affected
than its expression it is possible that other proteases or
inhibitors participating in the activation of MMP-2 are affected
by Tst-1 as well.
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Figure 1. MMP-19 promoter is repressed by Skn-1a and Tst-1 and contains a binding motif for Tst-1. The activity of MMP-19 promoter was assessed using a
luciferase-reporter assay by transient transfection of (a) COS-7 cells and (b) HaCaT keratinocytes with Skn-1a and Tst-1. (a) For each transfection 1898/LUC
vector and pRL-TK renilla luciferase vector as internal control were co-transfected with 0.02 or 0.04 mg (20 or 40% plasmid DNA) of either Tst-1 or Skn-1a vector
alone or together in low concentration (Tst-1þ Skn-1a). (a) COS-7 cells co-transfected with Tst-1 and Skn-1a in low concentrations (5 and 10% of plasmid DNA)
synergistically decrease the activity of MMP-19 promoter. (b) Transiently transfected HaCaT cells show inhibition of the MMP-19 promoter activity analogous to
COS-7 cells. Data are presented as average7SD and show the percentage of relative light units change against the control (*Po0.05 and **Po0.01). (c) The
promoter of MMP-19 does not contain a consensus binding sequence for Skn-1a but a putative binding site for Tst-1 with a sequence starting at position 278.
The sequence is denoted with capital letters indicating the core. The analysis of the MMP-19 promoter disclosed CREB binding protein consensus binding
sequences at positions 1917, 1898, and 1398, and CREB at 1398. The common elements TIE, AP-2, and TRE found in the MMP-19 promoter are
indicated.
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DISCUSSION
In this study, we have found that transcription factors of the
POU family Tst-1 and Skn-1a involved in the epidermal
differentiation process control expression of MMP-19 and
that Tst-1 influences also MMP-9 and MMP-2, but not MMP-
28. Although several other MMPs could be potentially
produced by basal keratinocytes their expression is generally
upregulated after epidermal injury. Thus, MMP-1 and MMP-3
are expressed by migrating keratinocytes in the leading
epidermal edge during wound closure (Pilcher et al., 1998,
1999). Although MMPs are essential for efficient wound
healing and play important role during development of
cutaneous tumors, it seems that they do not exert important
physiological function in healthy epidermis.
At the moment, we do not know why MMP-19 is
expressed by basal keratinocytes and which functions it
exerts but as it activates the IGF/IGF-1R pathway it may
contribute to proliferation of basal keratinocytes and, thus, to
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Figure 2. Tst-1 inhibits proliferation and the expression of MMP-19 in stably transfected keratinocytes. (a, upper panel) Two selected clones Tst-1/12 and Tst-1/14
with different expression level of Tst-1 were selected for further analysis. Tst-1 expression was analyzed using RT-PCR with expression of (a, lower panel)
glyceraldehyde-3-phosphate dehydrogenase as control. (b) Using the luciferase promoter assay both clones show reduced activity of the MMP-19 promoter
activity (*Po0.05). (c) In comparison to HaCaT cells both clones Tst-1/12 and Tst-1/14 exhibit decreased cell proliferation measured by [3H]thymidine
incorporation (**Po0.01). (d) Western blot analysis against involucrin shows a reduced expression in (e) Tst-1 clones that is confirmed by quantitative RT-PCR
(**Po0.01). (d, arrows) Antibodies against involucrin detect a 120-kD form and the 68-kD precursor form of keratinocyte cornified envelop. (f) Expression of
loricrin is upregulated in Tst-1 clones whereas (g) K 14 and (h) K5 are repressed. The band of 60-kD that represents K5 expression is indicated (h, arrow), the
lower band originates from cross-reactivity of the antibody.
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inhibition of keratinocyte differentiation (Sadowski et al.,
2003a). Indeed, IGF-1 is considered to possess important
regulatory functions in the epidermis as calcium-induced
differentiation of keratinocytes is inhibited in the presence of
IGF-1 (Wertheimer et al., 2000). The downregulation of
MMP-19 in suprabasal layers might be then needed for the
onset of the epidermal differentiation program. This is
supported by the expression pattern of MMP-19 in cutaneous
diseases such as psoriasis, tinea, or eczema, all of which
exhibit proliferative disturbance (Sadowski et al., 2003b).
MMP-19 may also be involved in keratinocyte movement or
release from the basement membrane as it possesses capacity
to process basement membrane proteins such as type IV
collagen, nidogen-1, tenascin C, and laminin 5 g2 (Stracke
et al., 2000; Titz et al., 2004; Sadowski et al., 2005). The
MMP-19-dependent processing of laminin 5 g2 chain leads to
an integrin switch favoring signaling via a3b1 integrin, which
promotes keratinocyte migration (Sadowski et al., 2005).
As the expression pattern of MMP-19 in the epidermis
follows that of K14 in the intact epidermis as well as in
epidermal diseases such as psoriasis, eczema, and tinea
(Sadowski et al., 2003b) we assumed that MMP-19 might be
regulated in keratinocytes in a similar manner as K5 and K14
(Fuchs and Green, 1980; Faus et al., 1994; Fuchs, 1995; Zhu
et al., 1999; Sugihara et al., 2001). As Skn-1a and Tst-1 inhibit
the expression of K5 and K14 and are expressed primarily in
differentiating keratinocytes (Goldsborough et al., 1993; Faus
et al., 1994; Sugihara et al., 2001) we studied if these
transcription factors also influence the expression of MMP-
19. Transient transfection of either COS-7 or HaCaT cells
with expression vectors harboring Tst-1 led to a dramatic
decrease of MMP-19 promoter activity. In contrast, Skn-1a
was less effective in HaCaT cells and showed no significant
effect in COS-7 cells. The concurrent expression of these
transcription factors augmented their inhibitory effect on the
MMP-19 promoter. Based on this effect it could be assumed
that Skn-1a and Tst-1 exhibit a synergistic inhibitory effect on
MMP-19 in suprabasal layers. Similar synergy was observed
in mice harboring deletion of both Tst-1 and Skn-1a/i
(Andersen et al., 1997). Although the epidermis of mice with
the deletion of Tst-1 develops without obvious changes, the
epidermis of mice deleted for both Skn-1a/i and Tst-1 is
hyperplastic and fails to suppress expression of K14.
To confirm that the suppression of MMP-19 promoter
parallels other processes known for the activity of Tst-1, for
instance keratinocyte differentiation, stably transfected Ha-
CaT cells were generated. As expected, ectopic expression of
Tst-1 upregulated the late differentiation marker loricrin,
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Figure 3. Impact of Tst-1 on MMP expression in keratinocytes. (a) The expression of MMP-19 at protein level is inhibited in clones Tst-1/12 and Tst-1/14 as
detected by western blot analysis. Arrows indicate different glycosylated forms of MMP-19. (b) Quantitative RT-PCR analysis of Tst-1 clones shows expression of
MMP-19 at the messenger RNA level. (c) Western blot analysis of MMP-28 expression in Tst-1 clones. (d and e) Expression and activity of gelatinases were
analyzed by gelatin zymography. Expression of MMP-9 was considerably reduced as could be deduced from the 92-kD band of pro-MMP-9. Expression of MMP-
2 in the Tst-1 clones is decreased about 20% as elucidated from analysis of the 72-kD form of pro-MMP-2. (d and e) The activation of MMP-2 is substantially
reduced as elucidated from the active 62-kD form of MMP-2. (e) Densitometric analysis of gelatinolytic bands is given as percentage to HaCaT cells.
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downregulated K5 and K14, and reduced the proliferation,
which reflects a shift towards keratinocyte differentiation
(Faus et al., 1994; Welter et al., 1996; Andersen et al., 1997;
Jang et al., 2000). In addition to the suppressed activity of
MMP-19 promoter, Tst-1 overexpression reduced MMP-19 at
the protein level. However, the decrease at messenger RNA
level was not significant pointing to an additional post-
transcriptional regulatory mechanism.
The analysis of the 50-flanking region of mmp-19 gene
revealed one consensus binding motif for Tst-1 but none for
Skn-1a. Thus, Tst-1 might act on the MMP-19 promoter
directly via the possible binding site as well as indirectly
whereas Skn-1a seems to regulate MMP-19 indirectly.
Nevertheless, we cannot exclude the possibility that cis-
acting elements for Skn-1a lay outside the region studied.
Such indirect regulations seem to be common among POU
factors. It has been shown that promoters of acetylcholine
receptor a3 and myeline Po gene are regulated by Tst-1
indirectly via protein–protein interaction instead of binding to
a DNA motif (Monuki et al., 1993; Jang et al., 2000). Tst-1
can also interact with high-mobility group protein HMG-I/Y
and thus increase its affinity to AT-rich elements (Leger et al.,
1995). With regard to indirect effects of Skn-1a, it has been
shown that this transcription factor modulates promoter
activity via binding to CREB and CREB binding protein/
p300. In this way, Skn-1a represses the promoter of K14
(Sugihara et al., 2001).
Although numerous publications document the expression
of MMPs during wound healing and in various pathologic
processes in the skin (Madlener et al., 1998; Pilcher et al.,
1999; Fisher et al., 2001; Inomata et al., 2003), factors
regulating their expression are mostly unknown (Parks and
Mecham, 1998). Here we show that MMP-19 typically
expressed in basal keratinocytes is downregulated by
transcription factors Skn-1a and Tst-1a that are involved
in epidermal differentiation. However, MMP-28, phylogen-
etically the nearest MMP, was not affected by Tst-1. In
contrast, MMP-9 that colocalizes with involucrin, (Kobayashi
et al., 2001), was also substantially inhibited at the expression
level. Analogous to MMP-19, the inhibition of MMP-9
might be also affected by Tst-1 because of its consensus
binding motif positioned similarly as in the promoter of
MMP-19. The expression of MMP-2 in HaCaT clones
overexpressing Tst-1 was slightly reduced but its conversion
to the active form was reduced considerably. This might
imply that another protease involved in the activation of
MMP-2, for instance MT1-MMP, or an MMP-2 inhibitor is
also affected by Tst-1 (Hernandez-Barrantes et al., 2000;
Overall et al., 2000).
Taken together, transcription factors Tst-1 and Skn-1a that
are expressed in suprabasal layers suppress the activity of
MMP-19 promoter, which in turn lead to downregulation of
MMP-19 expression. Tst-1 and Skn-1a affect also expression
and activation of MMP-9 and MMP-2, respectively, but not
MMP-28. Thus, Tst-1 and Skn-1a may be new important
tissue-specific regulators of matrix metalloproteinases. With
respect to differentiating events of the epidermis we propose
that the downregulation of MMP-19, analogous to the
repression of K5 and K14, marks one of the earliest steps in
keratinocyte differentiation.
MATERIALS AND METHODS
Cell culture and transfection
The HaCaT cell line was generously provided by N. Fusenig (DKFZ,
Heidelberg, Germany). HaCaT and COS-7 cells were maintained at
371C in a humidified atmosphere of 5% CO2 in DMEM (PAA, Linz,
Austria) supplemented with 10% FCS and 50 U/ml penicillin and
50 mg/ml streptomycin. The full-length cDNA of human Tst-1 and
Skn-1a, kindly provided by B. Andersen (University of California,
Irvine, CA), were subcloned into pcDNA3.1 (Invitrogen, Carlsbad,
CA). These vectors were transfected into HaCaT and COS-7 cells
using FuGENE 6 according to the manufacturer’s instructions
(Roche, Mannheim, Germany). Using this agent, we have routinely
reached 70–80% transfection in COS-7 cells and 20–25% transfec-
tion in HaCaT cells. For generation of stably transfected clones,
HaCaT cells were selected in 0.6 mg/ml G418 (PAA, Linz, Austria).
All experiments of this study were performed according to
institutional approvals of the Institute of Biochemistry, University of
Kiel.
Promoter activity
The promoter activity of MMP-19 was analyzed with the dual
luciferase assay (Promega, Madison, WI) using a firefly luciferase
vector containing a 1898-bp stretch of the 50-flanking region (–1898/
LUC) of the mmp-19 gene (Mueller et al., 2000). For transient
transfection, HaCaT and COS-7 cells at 5 104 cells/well were
transfected with a total amount of 0.1 mg DNA using FuGENE 6
(Roche) in serum-free DMEM containing 0.03 mM CaCl2. For each
transfection 0.06 mg of 1898/LUC vector and 0.02 mg pRL-TK
renilla luciferase vector as an internal control were co-transfected
with 0.005, 0.01, or 0.02 mg (5, 10, or 20% of plasmid DNA used for
transfection) of either Tst-1 or Skn-1a vector. To aim equal amounts
of DNA empty pcDNA3.1 vector was added to 0.1 mg (100% of
transfected plasmid DNA). As control 0.02 mg of empty pcDNA3.1
vector was used. To analyze the synergistic effect of Tst-1 and Skn-1a
co-transfection with 5% (0.005 mg) and 10% (0.01 mg) of both vectors
was carried out in COS-7 cells. Transfected cells were lysed after
48 hours cultivation. Luminescence was measured using a single-
sample luminometer (TD/20, Turner Design, CA) according to the
manufacturer’s manual (Promega). In order to measure MMP-19
promoter activity in HaCaT cells ectopically expressing Tst-1, cells
were transfected with 0.07mg –1898/LUC and 0.03 mg pRL-TK renilla
luciferase.
All assays were performed in quadruplicate in three separate
experiments. The average of these quadruplicate was taken to obtain
the relative luciferase activity, which is expressed in relative light
units as defined by the ratio of firefly to renilla luciferase activity
multiplied by the factor 104. Data are presented as average7SD and
show the percentage of relative light units change against the
control. Results were analyzed using student’s two-tailed paired
t-test.
Immunoblotting and gelatin zymography
Cells were lysed for 45 minutes on ice in 10 mM Tris-HCl buffer (pH
7.5) containing 1 mM EDTA, 150 mM NaCl, 1% Triton X-100, and
CompleteTM proteinase inhibitor (Roche, Germany). Protein content
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was determined using the bicinchoninic acid protein assay (Pierce,
Rockford, IL). Equal amounts of proteins were separated by SDS-
PAGE, followed by electrophoretic transfer onto a PVDF membrane
(Macherey-Nagel, Du¨ren, Germany). Membranes were blocked with
3% non-fat milk in TNT buffer containing 20 mM Tris-HCl, 500 mM
NaCl, and 0.05% Tween-20, pH 7.5. For detection, polyclonal
rabbit anti-MMP-19 (Chemicon, Temecula, CA), rabbit anti-loricrin,
rabbit anti-keratin 5, rabbit anti-keratin 14 (all Covance, Berkeley,
CA), and monoclonal mouse anti-involucrin antibodies (Sigma, St
Louis, MO) were used. For immunoblotting, the purchased anti-
MMP-19 antibodies (Chemicon) were preferred as they better
reflected the quantitative differences than the monoclonal anti-
propeptide domain antibodies CK 8/4. MMP-28 expression was
detected using polyclonal rabbit anti-MMP-28 antibodies, kindly
provided by S. Illman (University Helsinki, Finland). Bound
antibodies were detected using peroxidase-conjugated goat anti-
rabbit antibodies (Pierce, Rockford, IL) and the enhanced chemilu-
minescence plus Western Blotting Detection System (Amersham
Biosciences, UK). Signals were recorded with a Luminescent Image
Analyzer (FujiFilm, Tokyo, Japan).
For zymography, conditioned media supplemented with FCS or
without FCS standardized for cell numbers were mixed with a non-
reducing SDS sample buffer and loaded onto 10% polyacrylamide
gels containing 1 mg/ml gelatin (Sigma-Aldrich, Steinheim, Ger-
many). After electrophoresis, the gels were soaked in 2.5% Triton
X-100 to remove SDS. Gelatinolytic activities were developed in
50 mM Tris-HCl buffer containing 5 mM CaCl2, and 0.05% Triton
X-100, pH 7.5 at 371C for 24 hours. Lytic bands were visualized by
staining the gels with Coomassie blue R-250. Densitometric analysis
of lytic bands was carried out using the 2D AIDA image analyzer
software (RayTest, Straubenhardt, Germany). Values are given in
percent inhibition to untransfected HaCaT cells.
RNA isolation and RT-PCR
Total RNA from HaCaT cells was isolated using Trizols according to
the manufacturer’s instructions (Invitrogen, Carlsbad, CA). For the
generation of cDNA, 1mg RNA was incubated with 100 pmol oligo
dT primer and 20 U of Enhanced Avian HS reverse transcriptase
(Sigma, Germany) for 60 minutes at 421C. Glyceraldehyde-3-
phosphate dehydrogenase and Tst-1 were amplified in 22 and 30
cycles, respectively. Each cycle consisted of denaturation at 951C for
45 seconds, annealing for 30 seconds at 581C (Tst-1) or 501C
(glyceraldehyde-3-phosphate dehydrogenase), extension at 721C
for 60 seconds. The reaction was thereby kept in the exponential
range of amplification to obtain semiquantitative results. Oligonu-
cleotide primers were as follows: Tst-1, 50-GCACCTAGAACACGG
CAAG-30 and 50-CTTGAACTGCTTGGCGAACT-30 (product length,
526 bp); glyceraldehyde-3-phosphate dehydrogenase, 50-GAGAT
GATGACCCTTTTGG-30 and 50-GTGAAGGTCGGAGTCAACG-30
(product length, 386 bp).
cDNA synthesis, quantitative real-time PCR, and calculation of
CT values for MMP-19 and involucrin were carried out as described
(Held-Feindt et al., 2006). PCR was performed using the ABI 7700
Prism Sequence Detection System and TaqMan primer probes
(Applied Biosystems, Foster City, CA). Each sample was run in three
replicates. CT values were analyzed using student’s two-tailed paired
t-test; significances are indicated by asterisks (*Po0.05 and
**Po0.01).
Proliferation assay
HaCaT cells at 1.5 104 cells/well were cultured for 18 hours in
0.2 ml of DMEM with 10% FCS. For each experiment five wells per
clone were analyzed. After addition of 925 kBq [3H]thymidine/well
(Amersham Pharmacia, Biotech Ltd, UK) cells were cultured for final
6 hours. Cells were harvested onto glass fiber membranes using a
semiautomatic cell harvester (Inotech, Dottikon, Switzerland) and
thymidine incorporation was measured in a liquid scintillation counter
(MicroBeta Trilux, Perkin Elmer Wallac GmbH, Freiburg, Germany).
Values (c.p.m.) are presented as average7SD. Cell proliferation assays
were performed in three independent experiments.
Promoter sequence analysis
The MMP-19 promoter sequence (U89651; Mueller et al., 2000) was
analyzed using TFSEARCH (www.cbrc.jp/research/db/TFSEARCH.
html) and MatInspektor (www.genomatix.de/products/MatInspector/
index.html).
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